Abstract
Background:
The bioavailability of γ-tocopherol and metabolites of vitamin E after γ-tocopherol administration is not well understood. We investigated the effect of γ-tocopherol administration on the levels and metabolism of α- and γ-tocopherol in healthy volunteers.
Methods:
We measured two metabolites of vitamin E (2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman (α-CEHC) and 2,7,8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman (γ-CEHC)) in plasma and urine by high-performance liquid chromatography with electrochemical detection (HPLC-ECD) during administration of γ-tocopherol. Two groups of volunteers were enrolled. The γ-tocopherol group received two γ-tocopherol capsules (each containing 186.4 mg of γ-tocopherol and 5 mg of α-tocopherol) for 28 days, while the control group received d-α-tocopherol at 5 mg/day, which was the same dose as that given to the γ-tocopherol group. Blood and urine samples were obtained on days 0, 14, 28, 35, 42, and 56 after the initiation of γ-tocopherol administration.
Results:
The plasma γ-tocopherol concentration increased markedly during administration of γ-tocopherol and the plasma γ-CEHC concentration increased along with that of γ-tocopherol. The plasma α-tocopherol concentration decreased significantly during γ-tocopherol administration. The plasma concentration of α-CEHC decreased significantly and urinary excretion of α-CEHC tended to increase in the γ-tocopherol group. Urinary sodium secretion was significantly increased at 1 week after the cessation of γ-tocopherol administration, but there was no significant difference of urine volume between the two groups.
Conclusion:
Metabolism of α-tocopherol is accelerated and the plasma α-tocopherol concentration is decreased during γ-tocopherol administration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Clement M & Bourre JM (1997): Graded dietary levels of RRR-γ-tocopherol induce a marked increase in the concentrations of α- and γ-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats. Biochim. Biophys. Acta 1334, 173–181.
Galli F, Floridi AG, Floridi A & Buoncristiani U (2004): Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin. Nutr. 23, 205–212.
Galli F, Lee R, Atkinson J, Floridi A & Kelly FJ (2003): γ-Tocopherol biokinetics and transformation in humans. Free Radic. Res. 37 (11), 1225–1233.
Galli F, Lee R, Dunster C & Kelly FJ (2002): Gas chromatography mass spectrometry anarysis of carboxyethyl-hydroxychroman metabolites of α- and γ-tocopherol in human plasma. Free Radic. Biol. Med. 32 (4), 333–340.
Grammas P, Hamdheydari L, Benaksas EJ, Mou S, Pye QN, Wechter WJ, Floyd RA, Stewart C & Hensley K (2004): Anti-inflammatory effects of tocopherol metabolites. Biochem. Biophys. Res. Commun. 319, 1047–1052.
Hattori A, Fukushima T & Imai K (2000a): Occurrence and determination of a natriuretic hormone, 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxy chroman, in rat plasma, urine, and bile. Anal. Biochem. 281, 209–215.
Hattori A, Fukushima T, Yoshimura H, Abe K & Imai K (2000b): Production of LLU-a following an oral administration of γ-tocotrienol or γ-tocopherol to rats. Biol. Pharm. Bull. 23 (11), 1395–1397.
Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ & Floyd RA (2004): New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine. Free Radic. Biol. Med. 36 (1), 1–15.
Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S & Miller G (2003): Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 64, 978–991.
Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H & Inoue K (1997): Affinity for α-tocopherol transfer protein as a deteminant of the biological activities of vitamin E analogs. FEBS Lett. 409, 105–108.
Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW & Helzlsouer KJ (2003): Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 157, 335–344.
Ikeda S, Tohyama T & Yamashita K (2002): Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed γ-tocopherol. J. Nutr. 132, 961–966.
Jiang Q & Ames BN (2003): γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 17, 816–822.
Jiang Q, Christen S, Shigenaga MK & Ames BN (2001): γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 74, 714–722.
Jiang Q, Elson-Schwab I, Courtemanche C & Ames BN (2000): γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. USA 97, 11494–11499.
Kiyose C, Saito H, Kaneko K, Hamamura K, Tomioka M, Ueda T & Igarashi O (2001): α-Tocopherol affects the urinary and biliary excretion of 2,7,8,-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman, γ-tocopherol metabolite, in rats. Lipids 36, 467–472.
Liu M, Wallmon A, Mortlock CO, Wallin R & Saldeen T (2003): Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am. J. Clin. Nutr. 77, 700–706.
Lodge JK, Ridlington J, Leonard S, Vaule H & Traber MG (2001): α- and γ-Tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 36, 43–48.
Morinobu T, Yoshikawa S, Hamamura K & Tamai H (2003): Measurement of vitamin E metabolites by high-performance liquid chromatography during high-dose administration of α-tocopherol. Eur. J. Clin. Nutr. 57, 410–414.
Murray Jr ED, Wechter WJ, Kantoci D, Wang WH, Pham T, Quiggle DD, Gibson KM, Leipold D & Anner BM (1997): Endogenous natriuretic factors 7: biospecificity of a natriuretic γ-tocopherol metabolite LLU-α. J. Pharmacol. Exp. Ther. 282, 657–662.
Radosavac D, Graf P, Polidori MC, Sies H & Stahl W (2002): Tocopherol metabolites 2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman (α-CEHC) and 2,7,8,-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman (γ-CEHC) in human serum after a single dose of natural vitamin E. Eur. J. Nutr. 41, 119–124.
Resources Council, Science and Technology Agency (2000): Standard Tables of Food Composition in Japan, 5th Edition, Tokyo: National Printing Bureau (in Japanese).
Saito H, Kiyose C, Yoshimura H, Ueda T, Kondo K & Igarashi O (2003): γ-Tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor. J. Lipid Res. 44 (8), 1530–1535.
Smith KS, Lee CL, Ridlington JW, Leonard SW, Devaraj S & Traber MG (2003): Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients. Lipids 38, 813–819.
Tamai H, Manago M, Yokota K, Kitagawa M & Mino M (1988): Determination of alpha-tocopherol in buccal mucosal cells using an electrochemical detector. Int. J. Vitam. Nutr. Res. 58, 202–207.
Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE & Kayden HJ (1990): Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α-tocopherol into lipoproteins secreted by the liver. J. Clin. Invest. 85, 397–407.
Wechter WJ, Kantoci D, Murray Jr ED, D’Amico DC, Jung ME & Wang WH (1996): A new endogenous natriuretic factor: LLU-α. Proc. Natl. Acad. Sci. USA 93, 6002–6007.
Williamson KS, Gabbita SP, Mou S, West M, Pye QN, Markesbery WR, Cooney RV, Grammas P, Philipp UR, Floyd RA & Hensley K (2002): The nitration product 5-nitro-γ-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6, 221–227.
Acknowledgements
We are grateful to Mitsuzou Yoshikawa and Yoshiko Nakamura, dietitian of Osaka Medical College, for the helpful dietary study on all the volunteers.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoshikawa, S., Morinobu, T., Hamamura, K. et al. The effect of γ-tocopherol administration on α-tocopherol levels and metabolism in humans. Eur J Clin Nutr 59, 900–905 (2005). https://doi.org/10.1038/sj.ejcn.1602154
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602154
Keywords
This article is cited by
-
Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study
BMC Complementary Medicine and Therapies (2023)
-
Effect of the main dietary antioxidants (carotenoids, γ-tocopherol, polyphenols, and vitamin C) on α-tocopherol absorption
European Journal of Clinical Nutrition (2007)